203 related articles for article (PubMed ID: 18494264)
21. [Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].
Ni HC; Sun FH; Piao YS; Ma XL; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):391-5. PubMed ID: 22932407
[TBL] [Abstract][Full Text] [Related]
22. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
23. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
24. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
26. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells.
Schick V; Majores M; Engels G; Hartmann W; Elger CE; Schramm J; Schoch S; Becker AJ
Brain Pathol; 2007 Apr; 17(2):165-73. PubMed ID: 17388947
[TBL] [Abstract][Full Text] [Related]
27. The role of somatic mutational events in the pathogenesis of epilepsy.
Iffland PH; Crino PB
Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
[TBL] [Abstract][Full Text] [Related]
28. Detection of human papillomavirus in human focal cortical dysplasia type IIB.
Chen J; Tsai V; Parker WE; Aronica E; Baybis M; Crino PB
Ann Neurol; 2012 Dec; 72(6):881-92. PubMed ID: 23280839
[TBL] [Abstract][Full Text] [Related]
29. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
[TBL] [Abstract][Full Text] [Related]
30. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
[TBL] [Abstract][Full Text] [Related]
31. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
[TBL] [Abstract][Full Text] [Related]
32. Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway.
Onda H; Crino PB; Zhang H; Murphey RD; Rastelli L; Gould Rothberg BE; Kwiatkowski DJ
Mol Cell Neurosci; 2002 Dec; 21(4):561-74. PubMed ID: 12504590
[TBL] [Abstract][Full Text] [Related]
33. Cell injury and premature neurodegeneration in focal malformations of cortical development.
Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
[TBL] [Abstract][Full Text] [Related]
34. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
Jeong A; Wong M
J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
[TBL] [Abstract][Full Text] [Related]
35. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
Gerasimenko A; Baldassari S; Baulac S
Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
[TBL] [Abstract][Full Text] [Related]
36. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
[TBL] [Abstract][Full Text] [Related]
37. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
38. Identification of a somatic mutation in the RHEB gene through high depth and ultra-high depth next generation sequencing in a patient with Hemimegalencephaly and drug resistant Epilepsy.
Salinas V; Vega P; Piccirilli MV; Chicco C; Ciraolo C; Christiansen S; Consalvo D; Perez-Maturo J; Medina N; González-Morón D; Novaro V; Perrone C; García MDC; Agosta G; Silva W; Kauffman M
Eur J Med Genet; 2019 Nov; 62(11):103571. PubMed ID: 30414531
[TBL] [Abstract][Full Text] [Related]
39. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
40. Focal cortical dysplasia: Updates.
Pinheiro J; Honavar M
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
